Journal article

A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer

PLR Mitchell, R Basser, M Chipman, A Grigg, R Mansfield, J Cebon, ID Davis, F Appia, M Green

Annals of Oncology | OXFORD UNIV PRESS | Published : 2004

DOI: 10.1093/annonc/mdh144

Citation metrics

7Web of Science
7Scopus

Keywords

Granulocyte Colony-Stimulating Factor
Taxoids
Phase Ii Trial
Docetaxel
Paclitaxel
Oncology
Life Sciences & Biomedicine
Hematopoietic Stem Cells
Breast Neoplasms
Blood Progenitor Cells
Toxicity
Ovarian-Cancer
Taxotere
Humans
Dose Escalation
Peripheral Blood Stem Cells
Intravenous-Infusion
G-Csf
Multicenter
Colony-Forming Units Assay
Mobilisation
Aged
Antineoplastic Agents, Phytogenic
Science & Technology
Chemotherapy
Drug Therapy, Combination
Breast Cancer
Adult
Prospective Randomized-Trial
Mobilization
Middle Aged
Treatment Outcome
Neutropenia
Female